GxP compliance - An Overview

Although not unique to Component 11, the Act signaled a broader commitment to modernizing regulatory frameworks.Recognizing the need for a more versatile and hazard-primarily based approach, the FDA encouraged firms to put into practice controls according to the level of risk linked to electronic information and signatures.It addresses the look and

read more